Abstract:Melatonin is a methoxyindole synthesized and secreted principally by the pineal gland at night under normal light/dark conditions. The endogenous rhythm of secretion is generated by the suprachiasmatic nuclei and entrained to the light/dark cycle. Light is able to either suppress or synchronize melatonin production according to the light schedule. The nycthohemeral rhythm of this hormone can be evaluated by repeated measurement of plasma or saliva melatonin or urine sulfatoxymelatonin, the main hepatic metabolite. The primary physiological function of melatonin, whose secretion adjusts to night length, is to convey information concerning the daily cycle of light and darkness to body structures. This information is used for the organisation of functions, which respond to changes in the photoperiod such as the seasonal rhythms. Seasonal rhythmicity of physiological functions in humans related to possible alteration of the melatonin message remains, however, of limited evidence in temperate areas under field conditions. Also, the daily melatonin secretion, which is a very robust biochemical signal of night, can be used for the organisation of circadian rhythms. Although functions of this hormone in humans are mainly based on correlations between clinical observations and melatonin secretion, there is some evidence that melatonin stabilises and strengthens coupling of circadian rhythms, especially of core temperature and sleep-wake rhythms. The circadian organisation of other physiological functions depend also on the melatonin signal, for instance immune, antioxidant defences, haemostasis and glucose regulation. The difference between physiological and pharmacological effects of melatonin is not always clear but is based upon consideration of dose and not of duration of the hormone message. It is admitted that a "physiological" dose provides plasma melatonin levels in the same order of magnitude as a nocturnal peak. Since the regulating system of melatonin secretion is complex, following central and autonomic pathways, there are many pathophysiological situations where melatonin secretion can be disturbed. The resulting alteration could increase the predisposition to disease, add to the severity of symptoms or modify the course and outcome of the disorder. Since melatonin receptors display a very wide distribution in the body, putative therapeutic indications of this compound are multiple. Great advances in this field could be achieved by developing multicentre trials in a large series of patients, in order to establish efficacy of melatonin and absence of long-term toxicity.

Distribution Of Mt1 Melatonin Receptor Immunoreactivity In The Human Hypothalamus And Pituitary Gland: Colocalization Of Mt1 With Vasopressin, Oxytocin, And Corticotropin-Releasing Hormone

Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.

Co-Expression of Two Subtypes of Melatonin Receptor on Rat M1-Type Intrinsically Photosensitive Retinal Ganglion Cells

The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators

Melatonin suppresses sympathetic vasomotor tone through enhancing GABAA receptor activity in the hypothalamus

Distribution of Retinoic Acid Receptor-Α Immunoreactivity in the Human Hypothalamus

Thirty‐seven years of MT1 and MT2 melatonin receptor localization in the brain: Past and future challenges

Effects Of Melatonin On Blood Pressure In Stress-Induced Hypertension In Rats

Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces

Structural basis of ligand recognition at the human MT1 melatonin receptor

Distribution of Melatonin Receptor in Human Fetal Brain

Melatonin: Physiological effects in humans

Dual sources of melatonin and evidence for different primary functions

Anterior hypothalamic area: a neural site involved in the effects of meIatonin on blood pressure

The regulatory role of melatonin in pituitary thyroid-stimulating hormone synthesis through casein kinase 1α

Structural Basis of the Ligand Binding and Signaling Mechanism of Melatonin Receptors

Effect of Melatonin on Pro-Opiomelanocortin Mrna Expression in Arcuate Nucleus of Rat Hypothalamus

Seasonal Variation of Melatonin Secretion Across Various Segments of the Gastrointestinal Tract in Rats

Melatonin receptor (MTNR1A and MTNR2B) expression during the breeding season in the yak (Bos grunniens).

Melatonin Target Proteins: Too Many or Not Enough?

Melatonin: From the Hormone to the Drug?